Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 4/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | LCK | P06239 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1528 | 0.96 | ALDH1A1 (0.41) | ALDH1A1TSHRLMNAHSD17B10TDP1 | |
| SCHEMBL28578939 | 0.96 | ALDH1A1 (0.41) | ALDH1A1TSHRLMNAHSD17B10TDP1 | |
| SCHEMBL269725 | 0.96 | ALDH1A1 (0.41) | ALDH1A1TSHRLMNAHSD17B10TDP1 | |
| SCHEMBL19518538 | 0.96 | ALDH1A1 (0.41) | ALDH1A1TSHRLMNAHSD17B10TDP1 | |
| SCHEMBL31146798 | 0.96 | ALDH1A1 (0.41) | ALDH1A1TSHRLMNAHSD17B10TDP1 | |
| SCHEMBL2547046 | 0.96 | ALDH1A1 (0.41) | ALDH1A1TSHRLMNAHSD17B10TDP1 | |
| Ammonia Solution, Strong SCHEMBL18860444 | 0.96 | ALDH1A1 (0.41) | ALDH1A1TSHRLMNAHSD17B10TDP1 | |
| SCHEMBL23121571 | 0.93 | ALDH1A1 (0.39) | ALDH1A1TSHRLMNAHSD17B10TDP1 | |
| SCHEMBL22472309 | 0.93 | ALDH1A1 (0.39) | ALDH1A1TSHRLMNAHSD17B10TDP1 | |
| Water SCHEMBL141331 | 0.93 | ALDH1A1 (0.39) | ALDH1A1TSHRLMNAHSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6271 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122011253-A | Sieber resin and preparation method and application thereof | 江苏海普功能材料有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-12459883-B2 | Substituted hydroxystilbene compounds and derivatives synthesis and uses thereof | Kynan Duke IP, LLC (US) | 2025-11-04 | — | — | US | claimed |
| EP-4293009-B1 | FENFLURAMINE COMPOSITIONS AND METHODS OF PREPARING THE SAME | ZOGENIX INTERNATIONAL LTD (GB) | 2025-06-11 | — | — | EP | claimed |
| EP-4556480-A1 | COMPOUNDS CONSTITUTING C20-MODIFIED SALINOMYCIN DERIVATIVES, A METHOD FOR OBTAINING THE SAME, A COMPOSITION CONTAINING THE SAME AND A USE OF SAID COMPOUNDS | Fileclo Spolka Z Ograniczona Odpowiedzialnoscia (PL) | 2025-05-21 | — | — | EP | claimed |
| WO-2025098997-A1 | 1,4-BENZOTHIAZEPINES AND RELATED COMPOUNDS WITH CYCLOPROPANOL GROUPS AS MULTI-TARGETED DRUGS | GEORG-AUGUST-UNIVERSITÄT GÖTTINGEN STIFTUNG ÖFFENTLICHEN RECHTS, UNIVERSITÄTSMEDIZIN (DE) | 2025-05-15 | — | — | WO | claimed |
| EP-4548971-A1 | 1,4-BENZOTHIAZEPINES AND RELATED COMPOUNDS WITH CYCLOPROPANOL GROUPS AS MULTI-TARGETED DRUGS | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin (DE) | 2025-05-07 | — | — | EP | claimed |
| US-20240294541-A1 | COMPOUNDS CONSTITUTING C20-MODIFIED SALINOMYCIN DERIVATIVES, A METHOD FOR OBTAINING THE SAME, A COMPOSITION CONTAINING THE SAME AND A USE OF SAID COMPOUNDS | FILECLO SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (PL) | 2024-09-05 | — | — | US | claimed |
| EP-4380939-A1 | COMPOUNDS CONSTITUTING C20-MODIFIED SALINOMYCIN DERIVATIVES, A METHOD FOR OBTAINING THE SAME, A COMPOSITION CONTAINING THE SAME AND A USE OF SAID COMPOUNDS | Fileclo Spolka Z Ograniczona Odpowiedzialnoscia (PL) | 2024-06-12 | — | — | EP | claimed |
| EP-3801016-B1 | NOVEL CROP NUTRITION AND FORTIFICATION COMPOSITION | SAWANT ARUN VITTHAL (IN) | 2024-06-05 | — | — | EP | claimed |
| CN-118103377-A | Compounds constituting C20 modified salinomycin derivatives, process for obtaining the compounds, compositions containing the compounds and uses of said compounds | 菲莱克洛有限责任公司 | 2024-05-28 | — | — | CN | claimed |
| EP-1230240-B1 | PROCESS AND INTERMEDIATES FOR THE PREPARATION OF IMIDAZOLIDINONE ALPHA V INTEGRIN ANTAGONISTS | MERCK & CO INC (US) | 2003-07-23 | — | — | EP | claimed |
| EP-1319662-A1 | PROCESS FOR PREPARATION OF 7-OXABICYCLO 2.2.1]HEPT-5-ENE-2-CARBOXYLIC ACID DERIVATIVES | Kuraray Co., Ltd. (JP) | 2003-06-18 | — | — | EP | claimed |
| EP-1230240-A2 | PROCESS AND INTERMEDIATES FOR THE PREPARATION OF IMIDAZOLIDINONE ALPHA V INTEGRIN ANTAGONISTS | Merck & Co., Inc. (US) | 2002-08-14 | — | — | EP | claimed |
| US-6407241-B1 | REACTING THE CORRESPONDING WITH AMINE AND PHOSGENE; CYCLIZATION; THERAPY FOR BONE DISORDERS; ANTIINFLAMMATORY AGENTS | MERCK & CO., INC. | 2002-06-18 | — | — | US | claimed |
| WO-2001034602-A2 | PROCESS AND INTERMEDIATES FOR THE PREPARATION OF IMIDAZOLIDINONE ALPHA V INTEGRIN ANTAGONISTS | MERCK & CO., INC. (US) | 2001-05-17 | — | — | WO | claimed |
| WO-1999031506-A9 | PARALLEL SOLUTION PHASE SYNTHESIS OF LACTAMS | LILLY CO ELI (US) | 1999-09-16 | — | — | WO | claimed |
| US-5916902-A | Processes and intermediates for preparing 5, 7-dihydro-3- 2-(1-benzylpiperidin-4-yl)ethyl-!6H-pyrrolo- 4, 5-F!-1, 2-benzisoxazol-6-one | PFIZER INC. (US) | 1999-06-29 | — | — | US | claimed |
| WO-1999031506-A1 | PARALLEL SOLUTION PHASE SYNTHESIS OF LACTAMS | ELI LILLY AND COMPANY (US) | 1999-06-24 | — | — | WO | claimed |
| EP-0788500-A1 | PROCESSES AND INTERMEDIATES FOR PREPARING 5,7-DIHYDRO-3- 2- 1-BENZYLPIPERIDIN-4-YL ETHYL]-6H-PYRROLO- 4,5-f]-1,2-BENZISOXAZOL-6-ONE | PFIZER INC. (US) | 1997-08-13 | — | — | EP | claimed |
| WO-1996013505-A1 | PROCESSES AND INTERMEDIATES FOR PREPARING 5,7-DIHYDRO-3-[2-{1-BENZYLPIPERIDIN-4-YL}ETHYL]-6H-PYRROLO-[4,5-f]-1,2-BENZISOXAZOL-6-ONE | PFIZER INC. (US) | 1996-05-09 | — | — | WO | claimed |